M Cushman, LH Kuller, R Prentice, RJ … - Jama, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Postmenopausal ... Cited by 246 - Related articles - BL Direct - All 16 versions
T Baglin, R Luddington, K Brown, C Baglin - The Lancet, 2003 - Elsevier At 2 years, the cumulative recurrence rate in 570 patients was 11%. Incidence
was lowest after surgery-related VTE (0%) and highest after unprecipitated VTE
(19·4%) (p<0·001). 85% of patients were tested for heritable ... Cited by 207 - Related articles - All 8 versions
- ►lsh.is [PDF] W Burke - New England Journal of Medicine, 2002 - content.nejm.org Genetic testing can provide dramatic clinical benefits. A child known to have
multiple endocrine neoplasia type 2 (MEN-2) can be spared medullary carcinoma by
undergoing prophylactic thyroidectomy (Figure 1), 1 and an adult with ... Cited by 151 - Related articles - All 6 versions
RD Press, KA Bauer, JL Kujovich, JA Heit - Archives of Pathology and Laboratory Medicine, 2002 - arpa.allenpress.com Conclusions.—Consensus recommendations were generated for topics of direct
clinical relevance, including (1) defining those patients (and family members)
who should (and should not) be tested for FVL; (2) defining the preferred ... Cited by 89 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org SE Humphries, PM Ridker, PJ Talmud - Arteriosclerosis, thrombosis, and vascular biology, 2004 - Am Heart Assoc Genetic susceptibility tests are already advertised on the Internet to identify
individuals at above average risk for cardiovascular disease (CVD), such as deep
vein thrombosis, hyperlipidemia, or atherosclerosis, whereas other tests ... Cited by 73 - Related articles - BL Direct - All 8 versions
JD Curb, RL Prentice, PF Bray, RD Langer, L … - Archives of internal medicine, 2006 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 65 - Related articles - BL Direct - All 8 versions
I Bank, EJ Libourel, S Middeldorp, K … - Journal of Thrombosis and Haemostasis, 2005 - interscience.wiley.com Summary. Elevated levels of coagulation factor VIII:C (FVIII:C) are associated
with an increased risk for venous and arterial thromboembolism. Whether
relatives of patients with elevated levels of FVIII:C are also at increased ... Cited by 58 - Related articles - All 5 versions
D Dizon-Townson, C Miller, B Sibai, CY … - Obstetrical & Gynecological Survey, 2006 - journals.lww.com The fluoroquinolones are antibiotic agents that act by inhibiting bacterial DNA
gyrase. Because they are able to cross the placenta, they may have mutagenic or
carcinogenic effects on the developing fetus. The present in vitro study ... Cited by 59 - Related articles - BL Direct - All 7 versions
V Odlind, I Milsom, I Persson, A Victor - Acta obstetricia et gynecologica Scandinavica, 2002 - informahealthcare.com Page 1. Acta Obstet Gynecol Scand 2002: 81: 482–490 Copyright C Acta Obstet
Gynecol Scand 2002 Printed in Denmark . All rights reserved ... Cited by 53 - Related articles - BL Direct - All 10 versions
CY Vossen, J Conard, J Fontcuberta, M Makris … - Journal of Thrombosis and Haemostasis, 2005 - interscience.wiley.com Summary. Background: Reliable risk estimates for venous thrombosis in families
with inherited thrombophilia are scarce but necessary for determining optimal
screening and treatment policies. Objectives: In the present analysis, we ... Cited by 47 - Related articles - All 5 versions
